TACR1 and attention deficit-hyperactivity disorder: The findings from this study lead us to predict that a subgroup of ADHD patients, with a deficit in functional TACR1, will be more productive (i.e. complete more trials) and express a higher incidence of perseveration than other patients do and that these differences would be diminished by methylphenidate.